Danish researchers have offered more evidence that long-term inhaled corticosteriods given to control asthma in children do not have adverse effects on bone density.
Researchers at Kolding Hospital in Kolding, Denmark, studied 157 children with asthma who received an average daily dose of 504 µg of inhaled budesonide for at least 3 years. They included 111 control patients who had not used such a drug for more than 14 days. The researchers measured total body bone-mineral density, total body bone-mineral capacity, total bone calcium, and body composition. They found no differences between the 2 groups.
Voelker R. Corticosteroids and Bone Density. JAMA. 1998;279(10):739. doi:10.1001/jama.279.10.739-JWM80000-3-1
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: